Wyeth is seeking a pediatric indication for active immunization against invasive pneumococcal disease and otitis media caused by serotypes included in the vaccine. The vaccine includes six new
The Phase Ib placebo-controlled, triple combination study is anticipated to enroll up to approximately 50 treatment-naïve patients chronically infected with hepatitis C virus (HCV) genotype 1. The study
This placebo-controlled, randomized discontinuation trial is assessing the safety and efficacy of once-daily, oral AV-951 in metastatic renal cell carcinoma patients naive to VEGF targeted therapy at more
The transaction, with a net aggregate purchase price of approximately $190 million after deducting Kosan’s projected net cash balance at June 30, 2008, has been unanimously approved by
It is a one of its kind combination that has two blockbuster molecules, Atorvastatin and Ramipril combined together for the first time as a fixed dose combination. Atocor-R
Nuvo will issue to Paladin 961,538 common shares having a value of $125,000 for the right to commercialize this topical pain product. As part of the transaction, Paladin
Natus acquired all outstanding shares of Sonamed capital stock for $9 million cash, exclusive of direct costs of the acquisition. Jim Hawkins, president and CEO of Natus, said:
EnviroLogix’s new IsoQuick kit for mouse monoclonal isotyping is a lateral flow device (LFD) that EnviroLogix created and optimized for fast, accurate isotyping of mouse monoclonal antibodies. According
The primary objective of the Phase I combination study is to determine the recommended dose of seliciclib in combination with Tarceva. Secondary objectives include the evaluation of potential
The ruling, the culmination of a lawsuit filed in 2005 by generic drug manufacturer Ranbaxy, preserves Lipitor’s patent coverage in Australia through May 2012. Ranbaxy can appeal the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.